Download PDF

Other users also viewed these articles

Prevalence of metabolic associated fatty liver disease (MAFLD) in patients with gallstone disease. Study on a cohort of cases in South-Southeastern Mexico F. Roesch-Dietlen; A.G. Pérez-Morales; P. Grube-Pagola; M. González-Santes; F. Díaz-Roesch; A. Triana-Romero; L. Roesch-Ramos; J.M. Remes-Troche; M. Cruz-Aguilar;
Rev Gastroenterol Mex. 2023;88:225-31
Metabolic disorders across the body mass index spectrum in a Colombian population with nonalcoholic fatty liver disease C.E. Builes-Montaño; E. Pérez-Giraldo; S. Castro-Sánchez; N.A. Rojas-Henao; O.M. Santos-Sánchez; J.C. Restrepo-Gutiérrez;
Rev Gastroenterol Mex. 2024;89:64-9
Good clinical practice recommendations for the management of gastroesophageal reflux disease. A Latin American expert review M.A. Valdovinos-Díaz; A. Hani; C. Defilippi-Guerra; L. Fernando-Pineda; J.M. Remes-Troche; A. Riquelme; L.J. Abrahão-Junior; L. Aguilar-Paiz; C. Almonte-Nuñez; H. Burgos; C. Días; O. Gómez-Escudero; I. Hanna-Jairala; C. Olano; J.A. Olmos; A. Ortiz; G. Otoya; J.L. Tamayo-de la Cuesta; J. Suazo-Barahona; E. Vesco-Monteagudo; L.R. Valdovinos-García; J.S. Arenas-Martínez;
10.1016/j.rgmxen.2025.02.001